Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2005
03/31/2005US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder
03/31/2005US20050070530 Dipeptidyl peptidase inhibitors
03/31/2005US20050070491 Immunostimulatory nucleic acid molecules
03/31/2005US20050070485 Phenylalanine derivatives
03/31/2005US20050070466 Diagnostic imaging agents; targeting vectors which bind to integrin receptors; bicyclic arginine-glycine-aspartic acid derivatives; stablility; reduced background interference
03/31/2005US20050070459 treating Type I diabetes, septic shock, multiple sclerosis, inflammatory bowel disease (IBD) and Crohn's disease with BoroProline-Pinacol or other proline derivatives; dipeptidylpeptidase inhibitor
03/31/2005US20050069878 Proteins associated with cell growth, differentiation, and death
03/31/2005US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders
03/31/2005US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders.
03/31/2005US20050069592 Water-insoluble, antimicrobial silicate glass and use thereof
03/31/2005US20050069577 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies
03/31/2005US20050069576 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
03/31/2005US20050069568 Hydrogenation of nepetalactone using catalyst; plant extracts
03/31/2005US20050069547 Binding protein; therapy for bone tumors
03/31/2005US20050069533 Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and products thereof
03/31/2005US20050069505 Orally administrable composition for the photoprotection of the skin
03/31/2005CA2539842A1 Amidines and derivatives thereof and pharmaceutical compositions containing them
03/31/2005CA2539644A1 Hair restorer
03/31/2005CA2539306A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/31/2005CA2539165A1 Cinnamoyl compound and use of the same
03/31/2005CA2539162A1 Cinnamoyl derivatives and use thereof
03/31/2005CA2538960A1 Cinnamoyl compound and use of the same
03/31/2005CA2538867A1 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
03/31/2005CA2538760A1 Human .beta.-defensin secretion promoter
03/31/2005CA2536609A1 Anhydrous topical formulation for polyphenols
03/30/2005EP1518517A2 Drug-delivery endovascular stent and method for treating restenosis
03/30/2005EP1517924A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained
03/30/2005EP1517907A2 Azabicyclo-octane and nonane derivatives with ddp-iv inhibiting activity
03/30/2005EP1517897A2 Benzimidazole compounds and their use as estrogen agonists/antagonists
03/30/2005EP1517896A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity
03/30/2005EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
03/30/2005EP1517691A1 Use of dopamine receptor agonists for the treatment of cutaneous tumors, warts, and scars
03/30/2005EP1444197B1 Novel phenyl-propargylether derivatives
03/30/2005EP1390025B1 Use of coenzyme q (ubiquinone) and eicosapentaenoic acid (epa) for the treatment of non-hodgkin's lymphoma and psychiatric or neurological disorders
03/30/2005EP1389909A4 Antimicrobial compounds and methods for their use
03/30/2005EP1360184B1 Piperidine derivatives as neurokinin 1 antagonists
03/30/2005EP1147086B1 Compositions for the treatment of skin diseases
03/30/2005EP1124570A4 Novel neuropilin/growth factor binding and uses thereof
03/30/2005EP1105378B1 Quinazoline derivatives
03/30/2005EP1091942B1 Potassium channel blocking agents
03/30/2005EP0980369B1 Sulfonamides for treatment of endothelin-mediated disorders
03/30/2005CN1602360A Methods of increasing endogenous erythropoietin (EPO)
03/30/2005CN1602358A Recombinant fusion proteins and the trimers thereof
03/30/2005CN1602317A Angiopoietin-2 specific binding agents
03/30/2005CN1602311A Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
03/30/2005CN1602307A Substituted 6h-dibenzo[c, h]chromenes as estrogenic agents
03/30/2005CN1602207A Methods for inhibiting ocular processes
03/30/2005CN1602199A Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602187A Valdecoxib-based composition prepared by spray drying process and exhibiting rapid oral dissolution
03/30/2005CN1602181A Ceramide emulsions
03/30/2005CN1602172A Method and apparatus for the stimulation of hair growth
03/30/2005CN1600858A SiRNA for restraining melanin, preparation method and application
03/30/2005CN1600345A Ointment for quick curing trauma of burn and scald
03/30/2005CN1600324A Solution for removing freckle
03/30/2005CN1600322A Combination of propolis, preparation method and usage
03/30/2005CN1600310A Combination of Liranaftate gelatin and preparation method
03/30/2005CN1600306A Application of geldanamycin (C-3559) preparation of medicine for curing genital tract infection of condyloma accuminatum and herpes virus and on preparation of medicine for curing poliomyelitis
03/30/2005CN1600304A Application of extractive of ussurian grape on curing inflammatory disease
03/30/2005CN1600301A External remedy for treating psoriasis
03/30/2005CN1600300A Compound external remedy for treating psoriasis
03/30/2005CN1194978C Phosphinous and phosphonic acid derivs. used as medicaments
03/30/2005CN1194976C Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
03/30/2005CN1194750C Plane warts cream
03/30/2005CN1194744C Medicine for treating skin chap, and preparing method thereof
03/30/2005CN1194727C Acne-treating composition
03/30/2005CN1194723C Spot eliminating medicine and preparing process thereof
03/30/2005CN1194721C Sheqi facial appearance capsule and its preparation technology
03/30/2005CN1194720C Disinfecting liniment for treating skin disease
03/30/2005CN1194714C Chinese traditional medicine for treating psoriasis
03/30/2005CN1194710C Ointment for treating burn and scald and its preparing process
03/30/2005CN1194698C Puerarin injection and its prepn, process
03/30/2005CN1194692C Method of inhibiting skin damage of vitamin A analog
03/30/2005CN1194659C Natural hair-growing cream coated on eyebrow
03/29/2005US6872746 Isomeric fused pyrrolocarbazoles and isoindolones
03/29/2005US6872743 Antiinflammatory agents; sepsis shock; antiarthritic agents
03/29/2005US6872738 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
03/29/2005US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis
03/29/2005US6872735 LFA-1 antagonist compounds
03/29/2005US6872719 Antiinflammatory agents; autoimmune disease
03/29/2005US6872700 Methods for glucagon suppression
03/29/2005US6872400 Heat resistance; mixture with sequestering and neutralizing agent
03/29/2005US6872399 Dermatomycosis vaccine
03/29/2005CA2335186C Pyrrolo[2,3-d]pyrimidine compounds
03/29/2005CA2279897C Novel antioxidant mixture
03/29/2005CA2217169C Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
03/24/2005WO2005026138A1 2-naphthylimino-1,3-thiazine derivative
03/24/2005WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR
03/24/2005WO2005025600A1 Drug inhibiting mobilization of adhesive cells into peripheral blood
03/24/2005WO2005025598A1 Antibacterial drug for propionibacterium acnes
03/24/2005WO2005025538A1 Composition for medical use containing sugar chain-containing chitosan derivative and glycosaminoglycan
03/24/2005WO2005025520A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof
03/24/2005WO2005009331A3 Use of a cosmetic or pharmaceutical composition, comprising a lupeol-rich extract as an active ingredient for stimulating the synthesis of heat shock proteins
03/24/2005WO2005002537A3 Barrier formulation comprising a silicone based emulsion
03/24/2005WO2004112808A3 Therapeutic use of lipids extracted from mother of pearl
03/24/2005WO2004100889A3 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
03/24/2005WO2004068931A3 Amphiregulin antibodies and their use to treat cancer and psoriasis
03/24/2005WO2004017948A8 Use of lck inhibitor for treatment of immunologic diseases
03/24/2005WO2003077861A3 Water-based delivery systems
03/24/2005WO2002092759A9 Molecules for disease detection and treatment
1 ... 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 ... 1065